Navigation Links
Three PDX (Pralatrexate) Studies Presented at the 2007 AACR-NCI-EORTC Conference
Date:10/25/2007

MTD in NSCLC Identified; Phase 2 Study Planned

WESTMINSTER, Colo., Oct. 25 /PRNewswire-FirstCall/ -- Allos Therapeutics, Inc. (Nasdaq: ALTH), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that results from three PDX studies were presented as posters during the 2007 AACR-NCI-EORTC conference held October 22-26, 2007 in San Francisco, California. The posters described the effects of PDX (pralatrexate) in patients with non-small cell lung cancer (NSCLC), in patients with relapsed or refractory non-Hodgkin's lymphoma (NHL) and Hodgkin's disease, and in human cancer models in vivo and in vitro.

PDX in NSCLC (Phase 1)

The poster entitled "Phase 1 study of the antifolate pralatrexate when given with vitamin B12 and folic acid supplementation in patients with advanced non-small cell lung cancer (NSCLC)" presented results of this Phase 1 dose ranging study. In the study, a total of 22 patients with relapsed or refractory NSCLC were treated at doses of 150 to 325 mg/m2 of PDX. The maximum tolerated dose (MTD) was determined to be 270 mg/m2, which is twice that observed in a previous Phase 1 study in which PDX was administered without vitamin supplementation. Clinically significant radiologic responses were observed. Greater than 50% of patients (13/22) received two or more prior treatment regimens. Based on PDX clinical experience to date, the Company plans to initiate a randomized Phase 2 study of PDX in patients with NSCLC.

PDX in NHL (Phase 1/2)

The poster entitled "A Phase '2-1-2' Study of Two Different Doses and Schedules of Pralatrexate, A High Affinity Substrate for the Redu
'/>"/>

SOURCE Allos Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. The TripleMaster PCR System for three different amplifications
2. Cloning Based on Efficient Three-Fragment Assembly DNA Ligation
3. Three Micron TSK-GEL ODS-100V Columns for High Throughput LCMS
4. Three finalists named for UW-Madison CIO
5. Three state businesses receive technology grants
6. Leading cancer institute to install three TomoTherapy systems
7. Waukesha considers wireless bids from three firms
8. Computerworld top 100 includes three Wisconsin CIOs
9. 30 days to success: Three simple steps to create your own international startup
10. Three firms get state tech development grants
11. Three more Wisconsin firms to present at venture forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... , July 27, 2015 Junto Health, ... startups share information and develop new technology solutions, today ... Policy Group (SPG), a leader in health care policy ... now engage in a collaborative innovation process while, at ... latest trends in public policy, health care finance and ...
(Date:7/27/2015)... Princeton Junction, NJ (PRWEB) , ... July 27, 2015 , ... ... Awards, which identify and celebrate the top 100 most innovative technologies and services of ... ® which was named in the Software/Services category. The winners will be announced at ...
(Date:7/25/2015)... ... 25, 2015 , ... Technology leader Anton Paar offers the ... the surface temperature of the measuring prism. This is required to achieve the ... documentation are key requirements. It is likely that no refractometer manufacturers on the ...
(Date:7/24/2015)... ... July 24, 2015 , ... VetStem Biopharma, proudly announces a new ... stem cell therapy training and clinical opportunities. , “We are very excited to be ... the San Diego area. Stem cell therapy is an established treatment for arthritic conditions ...
Breaking Biology Technology:Junto Health Announces a Unique Partnership with Sachs Policy Group 2Junto Health Announces a Unique Partnership with Sachs Policy Group 3Junto Health Announces a Unique Partnership with Sachs Policy Group 4Visual Assay® Named Finalist in 53rd Annual R&D 100 Awards 2It’s T-Time for Refractometers: On-site Temperature Check Now Available 2VetStem Biopharma, proudly announces a new long term partnership with VCA Emergency Animal Hospital & Referral Center. 2VetStem Biopharma, proudly announces a new long term partnership with VCA Emergency Animal Hospital & Referral Center. 3
... Choices, More Options to Global ... ... Feb. 11,/PRNewswire- FirstCall/ -- DuPont (NYSE: DD ) and Precision ... the market faster. Terms of the agreement were not,disclosed., The ...
... RICHMOND, Va., Feb. 11 A report released,today, commissioned ... savings of approximately $378 billion over the next 20 ... U.S., The econometric study by economist Dr. Robert ... Administration, found that "...generic,versions of the top 12 categories ...
... 11 On Monday, January 28, The ... the first,Volumetric Modulated Arc Therapy (VMAT)* treatment ... To facilitate the treatment, the hospital,used its ... generation,linear accelerator control system., (Logo: ...
Cached Biology Technology:DuPont and Precision BioSciences Collaborate to Accelerate Crop Product Development 2Study by Leading Economist Identifies Potential for $378 Billion of Savings From Follow On Biologics 2Study by Leading Economist Identifies Potential for $378 Billion of Savings From Follow On Biologics 3Study by Leading Economist Identifies Potential for $378 Billion of Savings From Follow On Biologics 4Study by Leading Economist Identifies Potential for $378 Billion of Savings From Follow On Biologics 5Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital 2
(Date:7/2/2015)... , June 25, 2015 ... the addition of the "Natural Language Processing ... (Recognition, IVR, OCR, Pattern & Image Recognition) - ... offering. The key vendors occupying the ... IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute ...
(Date:6/29/2015)... 24, 2015 Research and ... "Latin America Biomedical Sensors Market - Growth, Trends ... The Latin America Biomedical Sensors market is estimated ... 2.04% over the period 2014-2020 The near ... the genetic formulation of each individual. These sensors can ...
(Date:6/24/2015)... 2015 The biologics safety testing market is ... the market include growth of the pharmaceutical and biological ... Over the years, the number of drug approvals in ... the FDA approved 225 drug applications and Health Canada ... Europe accounted for 3,822 of the pharmaceutical ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Latin America Biomedical Sensors Market Report 2015-2020 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4
... evolution works by reversing the process, reconstructing a 530-million-year-old ... genes that descended from the archaic gene. , "It ... evolution has occurred and is occurring, and thus makes ... and co-chairman of human genetics at the University of ...
... important new paper forthcoming in the June issue of ... University) argues against the widely held theory that the ... a large, replicating molecule such as RNA. Instead, ... a "stupendously improbable accident," presenting the more plausible idea ...
... of Warwick has found that sleep deprivation is associated ... obese for both children and adults. , Early results ... University of Warwick's Warwick Medical School were presented to ... the University of Warwick. , The research reviewed current ...
Cached Biology News:Scientists reverse evolution 2Scientists reverse evolution 3Scientists reverse evolution 4Scientists reverse evolution 5Sleep deprivation doubles risks of obesity in both children and adults 2
... Detergent Clean-up Micro Kit provides a fast and ... Triton X-100 and other detergents from small samples ... Norgens patented protein resin as an ion exchanger. ... g of either acidic or basic protein.A complete ...
Compound(s) screened through any number of client selected assays. Client also selects number of concentrations and replicates....
... cells form from a hematopoietic stem cells ... to the bone surface and lowering the ... around 4.5. The bone mineral is then ... and function is controlled primarily by Macrophage ...
Values of steady state parameters for enzyme activities are determined....
Biology Products: